Model Aims to Predict Immunotherapy-Related Myocarditis Fatalities
Top Thought Leaders in Topic Area
Topic Name
ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.
KOL Commentary
Watch